Study to Assess the Effect of Intravenous Supplementation of Omega-3 Fatty Acids on Outcome of Recipients in Living Donor Liver Transplantation
NCT ID: NCT04030065
Last Updated: 2019-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
124 participants
INTERVENTIONAL
2018-12-02
2019-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Omega 3 Lipid Emulsions and Liver Transplantation
NCT01957943
Uptake of an Omega-3 Oil in Healthy Adults
NCT05650294
The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease
NCT01277237
The Effects of Omega-3 Fatty Acids in Renal Transplantation
NCT01744067
Effects of Omega-3 Fatty Acids on Outcome After Major Liver Resection
NCT01884948
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Arm - omega 3 fatty acid
Omega 3 fatty acid
10% Omega-3 fatty acid oil will be supplemented in intravenous form from preoperative day 1, intra-operatively (anytime during surgery before reperfusion of graft) and from post operative day 1 to day 5 in the study group. The preparation used will be 100 ml injection which contains 10 gm of Omega 3 fatty acids.
Control Arm - No intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Omega 3 fatty acid
10% Omega-3 fatty acid oil will be supplemented in intravenous form from preoperative day 1, intra-operatively (anytime during surgery before reperfusion of graft) and from post operative day 1 to day 5 in the study group. The preparation used will be 100 ml injection which contains 10 gm of Omega 3 fatty acids.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patients
* Those who consent
Exclusion Criteria
* Re-transplantation
* Known allergy to the study emulsion
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Liver and Biliary Sciences, India
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vivek Rajendran
Senior Resident, Department of HPB surgery and Liver transplantation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Viniyendra Pamecha, Professor
Role: STUDY_CHAIR
Professor and head , Department of HPB surgery and liver Transplantation, ILBS, New Delhi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of liver and biliary Sciences
New Delhi, , India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Senior Resident
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ILBS-livertransplant-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.